Articles tagged with Urology
A University of Pittsburgh study shows Botox injections significantly reduce irritative symptoms and improve quality of life index by 62.3% and 56.5% respectively. Patients experienced increased flow rate and decreased residual urine without significant side effects.
New studies release at the American Urological Association (AUA) show Enablex significantly reducing overactive bladder symptoms, including incontinence episodes and nocturia. Enablex improved efficacy parameters associated with OAB without CNS or CV safety concerns.
Researchers found that quality of life for men treated for prostate cancer continues to evolve long-term, with some experiencing improvements and others worsening. Sexual function remains a significant concern for survivors, with reported lower quality of life compared to non-cancerous individuals.
Researchers at the University of Pittsburgh have identified a potential biomarker, RCCA-5, which may help detect renal cell carcinoma in its early stages. Early detection is crucial for effective treatment, and RCCA-5 shows promise as an effective marker for urologic cancers.
A UMHS study found that African-American men with a history of gonorrhea are more likely to develop prostate cancer. The research suggests an inflammatory effect from the bacterial infection may trigger pre-existing cancerous cells to multiply, increasing risk.
A University of Pittsburgh study found that women with overactive bladder experience reduced sexual function and thoughts. Overactive bladder affects half of the 17 million Americans suffering from it, significantly impacting their quality of life.
A six-year study by University of Pittsburgh researcher found botox injections to be a safe and effective treatment for bladder dysfunction, reducing incontinence in 67.2% of patients. The therapy works by blocking muscle contractions, restoring normal bladder function and improving quality of life.
A study found that robotic doctor visits increased patient comfort and accessibility to medical information, with 57% suggesting it should become a standard practice. Patients preferred having their own physician conduct telerounds over others.
A new study published in Urology found that men taking AVODART for four years experienced a significant reduction in urinary symptoms and prostate volume, with an average symptom improvement of 6.1 points on the AUA-SI. Long-term treatment also resulted in low incidence of drug-related side effects.
A new biomarker, EPCA, has been discovered that can detect prostate cancer earlier than traditional methods. The marker is expressed in the tumor and throughout the prostate in men with prostate cancer.
The new robotic procedure uses remote control technology to perform the surgery, reducing recovery time and scarring. Women who have undergone the procedure have shown no signs of recurrence, making it a promising alternative to traditional full surgery.
A study found that nearly one-third of online bladder cancer information is outdated and inaccurate, with limited information on treatment options and follow-up care. The researchers recommend using reliable sources such as the National Cancer Institute and MEDLINEplus for accurate information.
A team led by Queen's urologist Dr. J. Curtis Nickel will investigate herbal remedies like saw palmetto and pygeum africanum for treating BPH, prostatitis, and bladder disease. The study aims to determine the true effectiveness and safety of these alternative therapies.
A study found that Viagra took effect within 14-20 minutes for many men, with over half experiencing erections leading to successful intercourse. The medication was well-tolerated, with no patients discontinuing treatment due to side effects.
A study at Johns Hopkins Medicine found that IVF births are associated with a higher incidence of exstrophy-epispadias complex, a rare birth defect affecting the bladder, pelvic bones, and genitals. Researchers estimate the risk is up to 7.3 times more common in IVF children compared to the general population.
Researchers have identified a genetic link between macrophage scavenger receptor-1 (MSR1) and increased risk of prostate cancer. MSR1 mutations were found in approximately 12.5% of African American men with prostate cancer, compared to 1.8% without the disease.
A new study by Columbia University Irving Medical Center reveals significant differences in PSA (Prostate-Specific Antigen) and PSAD (Prostate-Specific Antigen Density) test measurements between Caucasian and Hispanic men. The study found that while PSAD can accurately predict cancer risk in Caucasians, it is less effective in Hispanic...
In a study, 50 patients with various voiding dysfunctions reported a 82% decrease or absence of incontinence after Botox injections. The treatment alleviated symptoms for approximately six months without long-term complications. Overactive bladder affects 17 million Americans, causing significant quality-of-life issues.
A nationwide study of over 1,500 Hispanic, white, and black men found that erectile dysfunction (ED) affects approximately 20% of Hispanic men, 22% of whites, and 24% of blacks. The study also revealed a strong link between ED and cardiovascular disease, as well as diabetes.
Researchers at Johns Hopkins Medicine found that bladder exstrophy causes more extensive pelvic girdle bone defects than previously known. The study reveals an outward flare of the hip bone and rotation of the entire pelvic girdle, impacting surgeons' understanding of these defects.
University of Florida surgeons have improved a bladder removal technique, reducing complications and improving patient outcomes for those with severe bladder problems. The new method minimizes blood loss and is well-tolerated by patients, making it an ideal approach for those too ill to undergo standard surgery.
A recent UT Southwestern Medical Center study found that 20% of women with lower urinary-tract symptoms, including incontinence, had undiagnosed bladder obstructions. The researchers used urodynamics testing to identify the subset of women who would benefit from more specialized treatment.
More than 1,500 original research studies on urologic diseases will be presented at the meeting, including prostate cancer, male and female sexual dysfunction, incontinence, and kidney stone disease. Key findings include data on prostate cancer costs, PSA screening, and outcomes after radical prostatectomy.
A study by Johns Hopkins researchers found that videotaping surgeries can improve outcomes in radical prostatectomy. The study, which involved 62 patients, showed that minor differences in surgical techniques can have a major impact on results. Surgeons who perform successful procedures should review the footage to identify key factors.
The American Urological Association's 93rd Annual Meeting featured groundbreaking research on prostate cancer, erectile dysfunction, and kidney diseases. Researchers presented studies showcasing the importance of PSA testing in African American men and the effectiveness of sildenafil in treating erectile dysfunction.
Researchers from 95 medical centers found that finasteride significantly reduced prostate surgery and urinary retention risk. Over four years, patients treated with Proscar experienced a 20% prostate size reduction and lower risks of complications.